# OnCo record nct07218926 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07218926/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07218926", "NCT07218926" ;
  schema:name "A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy"@en ;
  schema:alternateName "StrateGIST 3"@en ;
  schema:description "A phase 3 trial testing IDRX-42 in gastrointestinal stromal tumour, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07218926/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07218926> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2025-12-03" ;
  onco:cancers <https://onco.cc/cancers/gist/>, <https://onco.cc/cancers/gist-imatinib-resistant/> ;
  onco:drugs <https://onco.cc/drugs/idrx-42/> ;
  onco:companies <https://onco.cc/companies/gsk/> .